New Treatment For Weight Loss And Muscle Wasting In Cancer Patients

by Gopalan T on  August 27, 2010 at 1:55 PM Cancer News
  •   Print
  •   Share
  •   Comments
  •  Text 
The cause and development of cancer cachexia is not fully understood, although an imbalance of chemicals known as free radicals is thought to play a major role. Restoring the balance of free radicals is the focus of the Deakin study which is expected to take three years to complete.

“Free radicals occur naturally in the body and are not harmful in low levels. Under normal circumstances free radicals are kept under control by antioxidants,” explained Ms Vanessa Vaughan, a PhD student working on the project.

“However in cachexia the balance is tipped, with free radicals causing serious damage to DNA and body proteins. Protein production is significantly decreased and breakdown is dramatically increased. Muscle wasting is the inevitable outcome.

“We will be testing two existing therapies in combination to evaluate their effectiveness in stabilising the free radicals and preventing muscle breakdown.

“The first is oxypurinol, which is closely related to a drug used for over 50 years to treat gout. Oxypurinol suppresses a free radical producing enzyme believed to be overactive in patients with cachexia. The second is an omega 3 fatty acid called eicosapentenoic acid (EPA), which reduces free radical production.”

The project recently received a funding boost from the Victorian Government, with Ms Vaughan awarded a Victorian Cancer Agency Palliative and Supportive Care in Cancer scholarship through the Victorian Cancer Agency.

“This funding support means that I can fulfill my passion to work in the field of cancer research,” Ms Vaughan said.

“Cancer cachexia is a devastating, under-researched condition. I am pleased to be able to work on a project that could have direct, positive outcomes for cancer patients.”

As well as Dr Lewandowski and Ms Vaughan, the project team includes Deakin PhD student Eddie Hinch, Deakin postdoctoral fellow Melanie Sullivan-Gunn, and Barwon Health’s Regional Director of Palliative Care, Associate Professor Peter Martin.



Source-Medindia
Previous Page 2 Page 1 | 2 
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Cancer
Looking for information on cancer? Go through medindia's Cancer quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cancer
Complete Medindia Resources
News Categories:  
Kidney Health Center

Cancer Related News

» Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients » Post Surgery Will the Tumour Return? New Breast Cancer Test to Predict Exactly
» Scientists Develop Compound That Triggers Cancer Cell Death » Iraqi National Hopes to Find Affordable Treatment for His Cancer in India
» New Technique can Help Doctors Detect Pancreatic Cancer » Colorectal Cancer Risk Factors Probed
» Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency' » No Need for PSA-Based Screening for Prostate Cancer: Task Force
Read More >>